As Global Coronavirus Cases Climb, More Areas on Lockdown

An increase in confirmed infections, particularly in Italy, Iran, and South Korea, has led to heightened measures to prevent the spread of the virus SARS-CoV-2.

Written byAshley Yeager
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: © ISTOCK.COM, POWEROFFLOWERS

The number of confirmed cases of COVID-19, the respiratory disease caused by the virus SARS-CoV-2, now sits at 79,4361, with 28 countries reporting documented illnesses, the World Health Organization reported today (February 24). The disease has killed 2,618 people in China and 23 people in other countries.

As more countries report new cases, South Korea, the country second hardest hit by the disease, has changed its national threat level to “red alert” and is prepared to implement lockdowns of affected cities and travel restrictions. Cases there had topped 600 with six deaths as of yesterday, NPR reports, with many new cases among members of a secretive Christian sect, according to the Los Angeles Times. It is the first time the country has issued a red alert since the outbreak of H1N1 swine flu in 2009.

Iran also reported a rapid rise in cases, with the outbreak ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Ashley started at The Scientist in 2018. Before joining the staff, she worked as a freelance editor and writer, a writer at the Simons Foundation, and a web producer at Science News, among other positions. She holds a bachelor’s degree in journalism from the University of Tennessee, Knoxville, and a master’s degree in science writing from MIT. Ashley edits the Scientist to Watch and Profile sections of the magazine and writes news, features, and other stories for both online and print.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies